Market revenue in 2024 | USD 52.7 million |
Market revenue in 2030 | USD 95.4 million |
Growth rate | 10.4% (CAGR from 2025 to 2030) |
Largest segment | Deoxy nucleotides |
Fastest growing segment | Deoxy nucleotides |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deoxy nucleotides, Dideoxynucleotides, Nucleotides for RNA synthesis (rNTP), Labelled nucleotides |
Key market players worldwide | Thermo Fisher Scientific Inc, Roche, Biorigin, DSM, Promega, Agilent Technologies Inc, ABF Ingredients |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleotide market will help companies and investors design strategic landscapes.
Deoxy nucleotides was the largest segment with a revenue share of 54.46% in 2024. Horizon Databook has segmented the UK nucleotide market based on deoxy nucleotides, dideoxynucleotides, nucleotides for rna synthesis (rntp), labelled nucleotides covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UK nucleotide market , including forecasts for subscribers. This country databook contains high-level insights into UK nucleotide market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account